Juliet Williams

Head of Research at Kymera Therapeutics

As Senior Vice President, Head of Biology at Kymera Therapeutics, Juliet brings more than 20 years of drug development experience, including service at Novartis, Sanofi, Millennium, and Curis. Prior to Kymera, Juliet was the Head of Oncology Biology and Small Molecule Drug Discovery at Novartis Institutes for Biomedical Research and served as the Head of Oncology Pharmacology at both Novartis and Sanofi. Juliet holds a degree in Natural Sciences (Biochemistry) from the University of Cambridge and a PhD in Developmental Biology from University College London. Juliet subsequently completed a Wellcome Postdoctoral Fellowship at University College London in Developmental Biology.

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Kymera Therapeutics

6 followers

Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.


Industries

Employees

51-200

Links